MYOS RENS Tech (MYOS) Reports Q1 Loss of $0.09

Go back to MYOS RENS Tech (MYOS) Reports Q1 Loss of $0.09

MYOS RENS Technology Reports First Quarter 2020 Financial Results Including a 95% Increase in Net Revenues

May 8, 2020 8:00 AM EDT

In April 2020, a 100-Dog Veterinary Study Showing Fortetropin®'s Impact on Dogs Recovering from TPLO Surgery, was Published in the Peer-Reviewed Journal, PLOS ONE

CEDAR KNOLLS, N.J., May 8, 2020 /PRNewswire/ -- 

... More